Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Enterprise Value (2021 - 2026)

Updated

Recursion Pharmaceuticals' Enterprise Value came in at $1.41 billion for Q2 2026, down 15.0% from $1.67 billion a year earlier but up 45.1% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Enterprise Value (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Recursion Pharmaceuticals reported Enterprise Value of -$643.06 million; for FY2025, it came in at $1.42 billion, down 32.1% from FY2024.

  • Enterprise Value carries a four-year compound annual growth rate of -12.3% (FY2021 to FY2025).
  • Going back by year, Enterprise Value was $2.09 billion in FY2024 (+8.7%), $1.92 billion in FY2023 (+107.9%), $922.87 million in FY2022 (-61.6%) and $2.4 billion in FY2021.
  • The five-year range for quarterly Enterprise Value is $633.81 million (Q1 2022) to $3.3 billion (Q3 2021).
  • Year-over-year, Enterprise Value has declined for three consecutive quarters, with an average decline of 7.9% over the last eight quarters.
  • The fastest year-over-year change in Enterprise Value over five years came in Q1 2024 (growth of 156.1%), and the weakest in Q2 2022 (a decline of 83.8%).
  • Business Quant data shows RXRX's Enterprise Value at $974.56 million (Q1 2026), $1.42 billion (Q4 2025) and $1.74 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.41 Bn
Mar 31, 2026 974.56 Mn
Dec 31, 2025 1.42 Bn
Sep 30, 2025 1.74 Bn
Jun 30, 2025 1.67 Bn
Mar 31, 2025 1.65 Bn
Dec 31, 2024 2.09 Bn
Sep 30, 2024 1.46 Bn
Jun 30, 2024 1.63 Bn
Mar 31, 2024 2.07 Bn
Dec 31, 2023 1.92 Bn
Sep 30, 2023 1.27 Bn
Jun 30, 2023 1.14 Bn
Mar 31, 2023 809.03 Mn
Dec 31, 2022 922.87 Mn
Sep 30, 2022 1.40 Bn
Jun 30, 2022 891.28 Mn
Mar 31, 2022 633.81 Mn
Dec 31, 2021 2.40 Bn
Sep 30, 2021 3.30 Bn
API Access

Recursion Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=RXRX&period=max&api_key=YOUR_API_KEY